FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

385060002: Prolonged-release oral tablet (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3636013018 Prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636014012 Prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3636019019 Extended-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1878701000052113 depåtablett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


3 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral tablet Is a Tablet false Inferred relationship Some
Prolonged-release oral tablet Is a Oral tablet false Inferred relationship Some
Prolonged-release oral tablet Has dose form intended site (attribute) Oral true Inferred relationship Some
Prolonged-release oral tablet Is a Modified-release oral tablet (dose form) true Inferred relationship Some
Prolonged-release oral tablet Has dose form administration method (attribute) Swallow (administration method) true Inferred relationship Some
Prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Prolonged-release oral tablet Has dose form release characteristic (attribute) Prolonged-release (release characteristic) true Inferred relationship Some
Prolonged-release oral tablet Has basic dose form (attribute) Tablet true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Metformin hydrochloride 1 g prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
pioglitazon 15 mg + metformin 1 g, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
trandolapril 1 mg + verapamilhydroklorid 240 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Theophylline 300 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
metoprololsuccinat 25 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
verapamilhydroklorid 400 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
disopyramidfosfat 100 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
vattenfritt teofyllin 600 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
orfenadrincitrat 100 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Oxycodone hydrochloride 40 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
nifedipin 90 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
kinidinsulfat 300 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
oxikodonhydroklorid 160 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
järn(II)glycinsulfat 562,5 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
metoprololsuccinat 50 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely felodipine 2.5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely mirabegron 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
loratadin 5 mg + pseudoefedrinsulfat 120 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Tramadol hydrochloride 400 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Mirabegron 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
metronidazol 750 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
metamfetaminhydroklorid 10 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Isosorbide mononitrate 40 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Sodium valproate 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
guajfenesin 600 mg + pseudoefedrin 60 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
prokainamidhydroklorid 250 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Nicotinic acid 750 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
klorfenaminmaleat 8 mg + metskopolaminnitrat 2,5 mg + pseudoefedrinhydroklorid 120 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
bupropionhydroklorid 100 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Fesoterodine fumarate 8 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Morphine sulfate 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
bupropionhydroklorid 300 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
bupropionhydroklorid 200 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nicotinic acid 500 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
guajfenesin 1 200 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Fluvastatin (as fluvastatin sodium) 80 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
diltiazem 180 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
takrolimus 750 mikrogram, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbamazepine 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
divalproexnatrium 500 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Nifedipine 30 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
desloratadin 2,5 mg + pseudoefedrin 120 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
fexofenadinhydroklorid 60 mg + pseudoefedrinhydroklorid 120 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Metoclopramide hydrochloride 15 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
diltiazem 300 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Felodipine 5 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Nifedipine 40 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
järn(II)sulfat 325 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
fexofenadinhydroklorid 180 mg + pseudoefedrinhydroklorid 240 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Nisoldipine 30 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Diclofenac sodium 75 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
isradipin 5 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
niacin 375 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely oxybutynin hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 1 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 2 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guanfacine (as guanfacine hydrochloride) 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guaifenesin 1.2 gram and pseudoephedrine hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Guanfacine (as guanfacine hydrochloride) 4 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely guaifenesin 600 milligram and pseudoephedrine hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
amoxicillin, vattenfritt (som amoxicillin) 775 milligram, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Nevirapine 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Metoprolol tartrate (as metoprolol succinate) 25 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Metoprolol tartrate (as metoprolol succinate) 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
fostemsavir 600 mg, depåtablett Has manufactured dose form False Prolonged-release oral tablet Inferred relationship Some
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely upadacitinib 15 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Ranolazine 375 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely paroxetine (as paroxetine hydrochloride) 25 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Aminophylline hydrate 225 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely aminophylline hydrate 350 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Biperiden hydrochloride 4 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Venlafaxine (as venlafaxine hydrochloride) 37.5 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Venlafaxine (as venlafaxine hydrochloride) 225 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Budesonide 9 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 50 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Quetiapine (as quetiapine fumarate) 150 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some
Clarithromycin (as clarithromycin citrate) 500 mg prolonged-release oral tablet Has manufactured dose form True Prolonged-release oral tablet Inferred relationship Some

Start Previous Page 3 of 4 End


This concept is not in any reference sets

Back to Start